A Community Health Concern: Respiratory Syncytial Virus and Children

References 

1. American Academy of Pediatrics . Respiratory syncytial virus. In:  Pickering LK,  Baker CJ,  Kimberlin DW,  Long SS editor. Red Book: 2009 Report of the Committee on Infectious Diseases 28th edition. Elk Grove Village, IL: American Academy of Pediatrics; 2009;p. 560–569
2. Cooper A, Banasiak N, Allen P. Management and prevention strategies for respiratory syncytial virus (RSV) bronchiolitis in infants and young children: A review of evidence-based practice interventions. Pediatric Nursing. 2003;29:452–456
   • MEDLINE
3. Leidy N, Margolis M, Marcin J, Flynn J, Frankel L, Johnson S, et al. The impact of severe respiratory syncytial virus on the child, caregiver, and family during hospitalization and recovery. Pediatrics. 2005;115:1536–1546
   • CrossRef
4. Paramore L, Ciuryla V, Ciesla G, Liu L. Economic impact of respiratory syncytial virus-related illness in the US. Pharmacoeconomics. 2004;22:275–284
   • MEDLINE
   • CrossRef
5. Ressel G. American academy of pediatrics releases policy statement on the prevention of respiratory syncytial virus infections. American Family Physician. 2004;69:993–994
6. Wegner S, Vann J, Liu G, Byrns P, Cypra C, Campbell W, et al. Direct cost analyses of Palivizumab treatment in a cohort of at risk children: Evidence from the North Carolina Medicaid program. Pediatrics. 2004;114:1612–1619
   • CrossRef